News

Kidney Patients Can Now Receive Pre- and Post-Transplant Care Closer to Home

Emory Transplant CenterBeginning in May 2012, the Emory Transplant Center will provide pre- and post-transplant services for renal patients in northwest Georgia at our new location in Cartersville. Along with our two existing satellite offices in Savannah and Dublin, the new office in Cartersville means that more Georgians can receive kidney transplant evaluations and follow-up care from Emory professionals without making a trip to Atlanta.

Emory’s Kidney Transplant Program:

  • Provides comprehensive evaluations for kidney and pancreas transplantation, as well as state-of-the-art transplant follow-up care
  • Offers a highly skilled team of specialists in the care of kidney transplant patients and living donors
  • Ranks as one of the top programs of its kind in the country, with success rates higher than expected for both patient and graft survival*
  • Performed 215 kidney transplant procedures in 2011 – the largest number of transplants in a single year in the history of the program

Emory Kidney Transplant Program Satellite Locations:

Emory Transplant Center –  Cartersville
(located in the Emory Heart & Vascular Center office)
970 Joe Frank Harris Parkway, Suite 280
Cartersville, Georgia 30120

Emory Transplant Center –  Dublin
(located in the Emory Heart & Vascular Center office)
2301 Bellevue Road, Suite 1000
Dublin, Georgia 31021

Emory Transplant Center –  Savannah
(located in the St. Joseph’s/Candler Hospital)
5534 Reynolds Street, Suite 212
Savannah, GA   31405

For more information about our locations and scheduling an appointment, visit our Kidney Transplant Program website.

 

*Source: Transplant by volume, Scientific Registry of Transplants Recipients (SRTR) national database

 

A Life Free From Anti-Rejection Medication Post-Transplant?

A life free from taking anti-rejection medications post-transplant…is it possible? After transplant, patients must take multiple medications to keep their bodies from rejecting the new organ. The side effects of these immunosuppressant drugs, for many, can be grueling. Side effects range from fatigue to high blood pressure to increased risk of infection. Researchers are currently evaluating whether it’s possible for kidney transplant patients to avoid use of immunosuppressant drugs post transplant. They’ve found that it’s possible that by not only transplanting the living donor organ but also some of the donor’s immune producing cells, it  may be possible to deceive the recipient’s immune system into accepting the new organ as its own.

To evaluate the likelihood of decreased reliance on immunosuppressant drugs for kidney transplant patients, researchers collect immune system-producing stem cells and other immunity cells from the living donor’s bloodstream. They infuse transplant patients with radiation and medications to wipe out part of their own bone marrow.  This allows the donated cells to squeeze in and create a sort of ‘mixed’ immunity that prevents rejection.  In essence, a kidney transplant patient would also be receiving a bone marrow transplant.

Dr. Kenneth Newell

Dr. Kenneth Newell

At the Emory Transplant Center, researcher Dr. Kenneth Newell, is compiling a registry of kidney recipients who somehow survive despite quitting the pills on their own because they couldn’t afford them or because of side effects – a truly rare case.  Thus far, Dr. Newell has discovered about three dozen of these cases.  The research team at Emory is testing these patients for biological markers that might explain why they fared well and who else is a good candidate.  This may provide clues that a completely separate part of the immune system plays a role in organ rejection/acceptance.

In the meantime, the Food and Drug Administration (FDA) approved the drug belatacept (Nulojix®) for the prevention of graft rejection after kidney transplants.  This is the first time a new class of drugs has been developed for transplant since the 1990s.  Belatacept has the potential to improve and simplify the medication regimens of kidney transplant recipients, being a less toxic alternative to calcineurin inhibitors, with fewer side effects such as high blood pressure, high cholesterol, kidney toxicity and diabetes.  It is now being offered at the Emory Transplant Center, where Emory physicians played a role in discovering this new drug.

Related Resources:

 

“My Offer Stands.” – Emory Transplant Nurse Donates Kidney to Patient

Clay Taber, Transplant Patient with Nurse Allison BatsonEmory University Hospital transplant nurse Allison Batson has spent many years caring for patients in need of a life-saving organ transplant. She has seen many patients’ lives saved because of the gift of organ donation … and many others lost because a matching organ simply could not be located in time.

Recently though, Allison was not only in the position to provide care and comfort at the bedside of a transplant patient in desperate need of a kidney transplant, she selflessly gave of herself – literally- by becoming an organ donor to 23 year-old Clay Taber of Columbus, Georgia.

Clay graduated from Auburn University in August and is soon to marry his college sweetheart in a few months. While he has been eagerly looking toward his future, over the last few months, he’s also been battling the fight of his life.

After his graduation, Clay’s family took a celebratory beach vacation at the Gulf of Mexico – not long after the unprecedented oil spill that occurred there. A few weeks later, Clay was not feeling well.

A doctor’s visit and standard blood tests uncovered Clay had Goodpasture’s Syndrome, a rare (approximately 1-in 1 million), life-threatening autoimmune disorder related to antibody formation in the body. Goodpasture’s syndrome is characterized by renal (kidney) disease and lung hemorrhage.

There is no exact cause known for Goodpasture’s disease, a disease in which the immune system fights the body’s own normal tissues through creating antibodies that attack the lungs and kidneys. Sometimes the disorder is triggered by a viral infection, or by the inhalation of gasoline or other hydrocarbon solvents – such as those found in crude oil.

Nurse Allison Batson, Patient Clay Taber

Nurse Allison Batson with Clay Taber

While Clay was lucky that the disorder was discovered before his lungs were affected, he was now suffering from complete kidney failure. He was transferred to Emory University Hospital in Atlanta, where he would spend numerous weeks on the 7th floor – the transplant unit, where he would undergo weeks of dialysis and plasmapheresis (blood purification procedure used to treat several autoimmune diseases.)

And that’s where the bond began.

“Immediately when Clay came onto our unit, he became a special patient that everyone just gravitated to,” said Allison Batson. “Here was this young man with everything in his life ahead of him, and he was fighting for his life. He quickly became friends of many of the staff, and really was just a tremendous inspiration to us all.”

Allison continued to visit with Clay during his weeks at the hospital, and a deeper connection began to form than the typical nurse-patient bond.

“I learned more about Clay, his family, his life, what he saw for his future. He wanted to get married to his sweetheart. He just graduated from college. The whole world was his, with the exception of this incredibly rare illness that hit him out of the blue. I have children his age, and I felt the same kind of pain his mother was feeling. Something inside me said I needed to do more.”

Soon Clay was strong enough to return home, where he would continue to receive dialysis treatment for a few months while waiting for a donor organ. Because Clay’s blood type is O-negative, finding a matching donor would prove to be challenging.

Clay’s mother, Sandra, would be tested as a possible match. She, however, would not qualify to be Clay’s organ donor. Then in late October, during a visit to Emory and the transplant unit where he regularly visited with friends and well-wishers, Clay, of course, also met with Allison.

“She said ‘If you’ll let me do this, I want to donate my kidney to you,” Clay recalls. “Something at that point just hit me. There are so many people in need of an organ transplant and have been waiting like me – even longer than me in many cases. And here is Allison offering to do this amazing thing. When she said ‘If you’ll let me,’ there was just something in those words. I couldn’t say no.”

Soon after, Allison would undergo the donor testing process that would eventually confirm her as a perfect match for Clay.

“People have asked me why I would do this for a stranger, or what if I had a family member in need one day, or why would I risk my own life or health for someone I barely know. My answer is because I can. Sure, I have children who might possibly be in need one day, but here was this young man right in front of me who needs help – today, and I am in a position to help him – today. If what I do for Clay causes more awareness among others that live organ donation is a possibility, then I can only hope that other lives will be saved because of my actions.”

On Tuesday, January 10th, the families of both Allison and Clay gathered in the early morning hours at Emory University Hospital. Smiles, tears and hugs were abundant between people who had formed an unbreakable bond over the course of the last few months, and had, in effect become extended family to one another.

In Operating Room #9, Allison underwent surgery to remove her kidney, while Clay was prepped for surgery just 30-feet away in Operating Room #8. Hours later, both patients were resting comfortably on the 7th floor of Emory University Hospital, where they had met by chance just months before. Both ready to start the new year in incredible fashion – with a new lease on life for Clay, and as a hero for Allison.

Related Resources:

 

Emory Researchers Investigate Methods for Reducing Transplant Rejection

Transplant Center OutcomesOrgan transplant rejection is a fear for many people faced with a possible need for transplantation. For this group of transplant candidates, some good news has come from recent research taking place at the Emory Transplant Center. Emory’s research shows that a new immunosuppressant protocol could convince a transplant recipient’s immune cells to switch sides by converting cells that normally recognize and attack transplanted organs to cells that control the immune response instead—and protect the grafted organ. This may give patients a better chance of avoiding rejection of the transplanted organ and help them wean off anti-rejection drugs over time, reducing the rate of long-term complications after transplant.

Dr. Mandy Ford

Mandy Ford, PhD

Emory’s Dr. Mandy Ford, assistant professor of surgery, is the senior author on the study, published this month in the Proceedings of the National Academy of Sciences Early Edition. The National Institute of Allergy and Infectious Diseases funded the study.

Emory transplant researchers found that an experimental combination of treatments can induce turncoat behavior among immune cells in mice with skin grafts. The combination included a transfusion of spleen cells from the donor, as well as a limited course of a drug that blocked immune cell signals from the CD154 molecule. The grafts survived for months. If one part of the combination was deleted, then the grafts didn’t last more than a few weeks.

“Using this treatment protocol, we found that a subset of cells that would normally attack the graft instead turn on a gene that instructs them to become graft-protective,” Dr. Ford says. “These protective cells, called regulatory T cells, are present in everyone’s immune system and normally prevent us from developing autoimmunity.”

Unfortunately, using drugs that block CD154 clinically in humans has the drawback of causing blood clots. But Dr. Ford says that Emory researchers are investigating the possibility of blocking CD154 signals in a different way to avoid the blood clotting mechanism, such as using donor-specific transfusions to control the immune system. The Emory Transplant Center is currently studying donor-specific transfusion (but with different drugs, not anti-CD154 drugs) as part of an experimental kidney transplant protocol.

We’ll keep you updated on this innovative transplant research. If you have questions on this research for our team, or thoughts you’d like to contribute, please feel free to use the comments section below!

Related Resources:

Kevin Jordan Returns to WFU Baseball Practice After Kidney Transplant

Kevin Jordan Wake Forest Kidney Transplant at EmoryIn February of this year, we shared with you a story of two amazing people, Kevin Jordan, a 19-year-old Wake Forest University baseball player, and his coach, Tom Walter, aka Coach Tom. To bring you up to speed, Kevin was diagnosed with ANCA vasculitis, an autoimmune disorder that typically leads to almost immediate kidney failure. At the time, Kevin was an all-star baseball player being actively recruited by both Wake Forest University (WFU) and Auburn, but he was faced with an illness that could potentially change his future not only in baseball, but in life. Kevin opted to join the crew at Wake Forest, but as his condition worsened, it became clear to both Kevin and Coach Tom that something would need to be done.

Kevin was in desperate need of a new kidney, and when neither his mother nor father met matching criteria to serve as a living donor, Coach Tom volunteered to be tested as a match. A match he was, and the story is pretty much a fairytale from there. Just months after joining the Wake Forest crew, Kevin and his coach would share a lifelong bond, making them family both on and off the field.

Kevin and Coach Tom came to Emory for the living donor kidney transplant, where transplant surgeons Dr. Kenneth Newell and Dr. Allan Kirk performed the procedure that not only gave Kevin renewed hope in life, but renewed hope that he would indeed return to the baseball diamond.

Fast forward seven and a half months later to today, Kevin is back and in good health, and the outfielder just attended the first Wake Forest Fall baseball practice of the year. Kevin’s recovery was not the only thing that’s proven to be speedy. Kevin ran the 60 yard dash in just 6.5 seconds, proving he has regained his health, strength, and speed. Kevin’s journey has struck a chord with people around the country, including those in the transplant community and sports communities. ESPN film crews attended the first WFU baseball practice of the year to share his progress with the country.

Our own Emory family members, particularly those who helped facilitate the kidney transplant from Coach Tom to Kevin have been equally touched and inspired by the story. “Kevin is a remarkable human being. And I think that’s one of the centerpieces of this story,” Dr. Allan Kirk, one of Kevin’s transplant surgeons said at the post-transplant press conference back in February. His recovery since that day has been equally as inspiring and remarkable, “when Kevin came to us, he was in bad shape, but he never lost hope. What he went through could have very easily derailed his plans. He’s a fighter. Coach Tom saw that in him, and so did we. Both myself and Dr. Newell have been touched to play a part in helping Kevin return to the sport that he loves, and in bringing a coach, player, team and community together to rally around someone who is truly a remarkably inspiring person. We’re very much looking forward to seeing what he accomplishes in the years to come,” remarks Dr. Kirk.

Read more on Kevin’s journey & his kidney transplant.

Top Transplant Doctors in Atlanta are at Emory

Each year, Atlanta magazine recognizes the top doctors in the metro Atlanta area as ranked by a thorough physician-led research process. The 2011 Atlanta Magazine Top Docs list included 318 doctors from across the Atlanta area and across specialties, highlighting the cream of the crop in specialties ranging from pediatric to geriatric services and everything in between. We’re very pleased to announce that not only can you find over 100 of the doctors recognized this year here at Emory, seven of them are our very own transplant team members!

Our Emory Transplant Center and its physician team are unique in that they are part of a multidisciplinary team providing care in seven core transplant specialty areas: kidney transplant, pancreas transplant, heart transplant, hand transplant, islet transplant, liver transplant & lung transplant. All of our doctors here at Emory Healthcare play a role in changing and saving lives, but often times our transplant team and the treatments they provide touch the lives of our patients and their families on a deeper level. And more often than not, receiving treatment from our transplant specialists is their last, if not only option. Thankfully, based on our program’s rankings, both from a statistical post-transplant quality outcome perspective, and the perspective of the physician research team, researchers at Castle Connolly Medical LTD, and Atlanta Magazine, the Emory Transplant Center is a great option to have.

We again congratulate each of our transplant surgeons for their dedication to providing outstanding patient centered care for our patients and families faced with less than idea circumstances that can warrant organ transplantation. It is because of our multidisciplinary team of transplant specialists and their compassion, that recognition such as the Atlanta Top Doctors rankings is given. If you’d like to shout out a particular transplant doctor who has impacted your life, please do so in the comments below. You can also find the listing of transplant surgeons recognized in this year’s rankings below. If you’re interested, check out the full list of Emory Healthcare doctors recognized as the best doctors in Atlanta.

Pancreas & Kidney Transplant Doctors:

  • Chris Larsen, MD, DPhil – Transplant Surgeon
  • Kenneth Newell, MD – Transplant Surgeon

Liver Transplant Doctors:

  • Stuart Knecthle, MD – Transplant Surgeon

Lung Transplant Doctors:

  • Seth Force, MD – Transplant Surgeon

Heart Transplant Doctors:

  • Andrew Smith, MD – Transplant Surgeon
  • Javed Butler, MD – Cardiologist

Hand Transplant Doctors:

  • Linda Cendales, MD – Transplant Surgeon

 

 

 

Hope for Kidney Transplant Patients Confirmed with FDA Approval of Drug Discovered at Emory

After decades of research and testing, the FDA approves belatacept, and a new class of transplant drugs first discovered by Emory doctors.

Back in September, Dr. Christian P. Larsen, Director of the Emory Transplant Center, shared a story with you here on our blog about belatacept, a new medication that was being studied to determine its ability to help block the immune system from graft rejection after kidney transplants. It’s been less than a year since we shared that story on belatacept with you, and since that time, the FDA has now approved belatacept for use for that exact purpose.

Christian Larsen, Emory Transplant Center Director

Dr. Christian Larsen, Director of Emory Transplant Center

Dr. Thomas Pearson

Dr. Thomas Pearson, Surgical Director, Kidney Transplant Program

Since the early 1990s, Emory surgeon-scientists Christian P. Larsen, MD, DPhil and Thomas C. Pearson, MD, DPhil have been searching for ways to promote immune tolerance of a transplanted organ. In collaboration with other Emory researchers and researchers at Bristol-Myers Squibb, they played a leading role in discovering belatacept and driving its development. The recent FDA approval of use of belatacept is the first time a new class of drugs has been developed for transplant since the 1990s.

So what led to this approval of a new class of drugs? From a research perspective, in the 1990s, Larsen and Pearson found that CTLA4-Ig, a fusion protein of which belatacept is a modified type, could control graft rejection in mice, but found that it didn’t work as well in non-human primates. Bristol-Myers Squibb researchers then developed a panel of hundreds of modified forms of CTLA4-Ig, and sifted through the mutated proteins to find two that could make CTLA4-Ig bind tighter to its target and work more effectively. Larsen and Pearson then showed that the enhanced version could prevent graft rejection in a non-human primate model for kidney transplant at Yerkes Research Center.

Once the determination was made that modified versions of the CTLA4-lg fusion proteins could work to prevent graft rejection on primates, belatacept was developed and tested. In two parallel studies with more than 1,200 participants over two years, patients taking belatacept had similar graft survival rates to those taking the calcineurin inhibitor cyclosporine, while maintaining higher kidney function and lower blood pressure and cholesterol. In addition, belatacept can be given every few weeks, in contrast to calcineurin inhibitors, which must be taken twice a day.

There is still room for improvement, though. Compared with cyclosporine-treated patients, belatacept-treated patients had a higher rate of early acute rejection – a temporary flare-up of the immune system against the donated kidney. However, in most cases the acute rejection was successfully treated with drugs and did not lead to graft failure. The Emory Transplant Center team is researching approaches to reduce this risk.

“Our goal is to achieve a normal life span for kidney transplant patients, and have them survive dialysis-free,” Larsen, Director of the Emory Transplant Center, says. “We believe belatacept can help us move toward that goal.”

Clinical trials are now also being conducted to determine if belatacept will have similar positive outcomes on liver transplant and pancreatic islet transplant patients.

For more information on belatacept, you can check out the video below. If you have additional questions, leave them in the comments for Dr. Larsen or Dr. Pearson and we’ll make sure they see them and give you a response!

For more information on the FDA’s approval of belatacept, visit: http://shared.web.emory.edu/whsc/news/releases/2011/06/fda-approves-transplant-drug-that-preserves-kidneys,-avoids-toxicity.html

One Good Transplant Deed Leads to Six Changed Lives

Imagine waking up one morning in good health and deciding out of the goodness of your heart to donate your kidney to someone you didn’t even know – anyone, anywhere. That’s exactly what Jon Pomenville of Anderson, SC, did recently. Little did he know, it would result in the drastic change of the lives of six individuals and their families.

Jon wasn’t looking for credit. In fact he was completely comfortable with remaining anonymous throughout the process. But during a recent visit to Emory University Hospital for a post-surgical follow-up, Jon met many of the individuals whose lives were changed – right there in the transplant clinic waiting room. Jon and four of the other donors and recipients in what is referred to as a paired kidney transplant were coincidentally scheduled for follow-up appointments within a short period of time of one another. It was only a matter of minutes before the patients – recipients and donors – two father and son combinations and Jon, the man who would give to anyone – were hugging, shaking hands, and recounting their lives and experiences. As one person began recounting the experience, eyes and ears began to focus on the tale being told from across a crowded room.

The Emory Transplant Center opened its Paired Donor Kidney Exchange Program in 2009, providing greater hope for patients in need of kidney transplants. A paired exchange donation is a process that allows healthy individuals to donate a kidney to either a friend, loved one, or even altruistically to a stranger, as was the case with Jon, despite incompatible blood matches. In paired donation, a donor and recipient are matched with another incompatible donor and recipient pair and the kidneys are exchanged between the pairs.

Paired donation is another form of living donor transplantation, which means the donated organ may come from a living person such as a friend, spouse or family member. Donated kidneys also come from recently deceased donors. While most kidneys from deceased donors function well, studies have shown that a kidney from a living donor, either a blood relative or an unrelated person, provides the greatest chance for long-term success.

Because of Jon’s donation, a young 7 year-old boy named Zion received a life-saving kidney from an unrelated donor because his dad, Mike, was able to donate. And Gerald Smith of Five Points, AL, received his life-changing kidney transplant because his son, Matt, a recent University of Alabama graduate, donated his kidney – to Zion. And lastly, 20 year-old Edward Hill of Macon, GA a young man with a history of health challenges, would also receive his kidney transplant (from an unknown donor) at Children’s Healthcare of Atlanta – completing the six-person cycle.

6 Person Paired Kidney Exchange

The decision Jon made to altruistically donate his kidney to a any person, anywhere set off a chain reaction that has drastically improved and changed lives. As the mother of one kidney recipient put it, “when we received that call a few weeks ago, it truly was a miracle. The donor program at Emory is an incredible thing that will help many people like my son, and I am as thankful as anyone could ever be because of it.”

The donor program at Emory is incredible, but without people like Jon Pomenville, and generous selfless acts of kindness such as his decision to donate his kidney, stories like this would not be possible. For more on this amazing story and the lives touched by Jon’s decision to donate, watch our short video below:

Emory Team Member Shares Living Donor Story in Honor of Donate Life Month

Pamela Emory Employee Living Donor

Pamela poses in front of a picture of her with her sister at Emory University Hospital

Lots of big news in the Emory transplant world as of late. We performed the Southeast’s first hand transplant, our 300th lung transplant, and most of you probably heard about the touching story of Wake Forest University baseball player, Kevin Jordan, and his coach, Tom Walter, who came to Emory to participate in a living donor kidney transplant. This last story, more than any other, has brought a tremendous amount of awareness around the notion of living donor transplants. April is Donate Life Month, and as such, we thought it appropriate to highlight another touching living donor transplant story, this one, between a member of the Emory family, Pamela Lesane, and her sister. We recently interviewed Pamela, who works for Emory Healthcare in Guest Services, about her journey as a living donor.

Morgan: Pamela, thanks so much for helping us promote awareness of living donor transplants. Tell us, where did your journey as an organ donor begin?

Pamela: My sister has suffered with kidney disease ever since she was born. At the time of the transplant she was suffering from both high blood pressure and kidney disease. After I started at Emory, I came into contact with a transplant coordinator who asked me if my sister had ever been evaluated for a transplant. She had not yet been evaluated, and a few weeks later my sister came to Emory and was placed on the waiting list. I asked to be the first one tested as a possible donor candidate. It turned out I was a match and the rest is history.

Morgan: What was the actual donation and transplant experience like for both of you?

Pamela: It was a blessing to finally be able to help my sister after watching her suffer her whole life with kidney disease. My sister often tells me that it’s like her life has started fresh since the transplant.  Her recovery time was short, only about 2 weeks, and she was able to notice an improvement in the way she felt within just a couple of days. Overall it was a wonderful experience for the both of us and brought us even closer than we already are.

Morgan: You mentioned you and your sister are closer now, specifically, how has the organ donation and kidney transplant affected your relationship with your sister?

Pamela: While my sister was on dialysis she was never able to travel as she had to come into the hospital three times a week. After the transplant, we were able to reach a new connection as we were able to travel and spend more time together. We have always been close but through the whole transplant experience we grew closer and are now able to spend more time together, which is wonderful.

Morgan: That’s wonderful to hear. Would you serve as her living donor again? Do you have any regrets?

Pamela: If I could go back in time I would do the transplant over and over again. I have absolutely no regrets, I was able to better my sister’s quality of life and we became closer as a result.

Morgan: Do you now encourage other people to consider being a living organ donor? If so, why?

Pamela: I do encourage other people to consider donation because it truly gives one individual the opportunity to provide someone with a second chance and a new lease on life. Especially if that person is a loved one, the satisfaction of being able to help a family member or friend get a fresh and healthy start to life is a wonderful feeling.

Morgan: How has working in health care changed your awareness and comfort levels with organ donation?

Pamela: If I hadn’t started working at Emory, I would never have come into contact with the people who made the transplant possible. Working in the health care field made me feel more at ease with the whole transplant process, because it was my peers who were looking out for both myself and my sister. I was able to listen to the doctor with a high level of comfort and was able to easily move forward with the transplant. That’s part of why sharing this story was so important to me. I realize that not everyone has the opportunity I did to be informed of the possibility of being a living donor. If you know someone in need of a transplant, it’s certainly worth looking into.

Morgan: Is there anything else you’d like to tell us about the experience?

Pamela: I would just like to thank the Emory community and specifically the transplant team because they truly changed my sisters life and our relationship.

If you have questions for Pamela, or would like to comment on her tremendous story, please use the comments field below.

Emory Performs First Hand Transplant in Georgia & Southeast, 14th Procedure in U.S.

Hand Transplant Story

A truly ground breaking procedure took place here at Emory this weekend. Transplant surgeons at Emory University Hospital have successfully completed the program’s first hand transplant. Not only is the complete hand transplant a first for Emory, but also the first hand transplant in the Southeast and only the 14th such procedure in the country. Emory transplant specialists performed this rare complete hand transplant procedure for a 21-year-old student out of Florida whose arm was amputated at the age of 1 due to Kawasaki Disease.

The hand transplant surgery lasted for 19 hours on Saturday, March 12 and involved a true multidisciplinary effort, including two teams (one dedicated to the patient and one to the donor arm) of transplant surgeons, specialists, nurses, and support staff. Since completion of the hand transplant, the patient has begun rehabilitation at Emory and will continue to rehabilitate in Atlanta for the next several months. As an IT major, when asked how the transplant would impact her life, her face lit up as she said, “I just want to be able to type.”

Emory’s Hand Transplant Program, established in 2007, is led by Dr. Linda Cendales, the only person in the United States with formal training in both hand and transplant surgery. Cendales is responsible for organizing the team that performed the first hand transplant in the U.S. and joined the Emory team from a program in Louisville that conducted 6 of the hand transplantations performed in the U.S.

If you have questions on the procedure or Emory’s Hand Transplant Program, please leave them in the comments section below.